Peri-ictal Water Drinking Lateralizes Seizure Onset to the Nondominant Temporal Lobe
Neurol 60:873-876, Trinka,E.,et al, 2003
Risk Factors for Fever in the Neurologic Intensive Care Unit
Neurol 60:837-841, Commichau,C.,et al, 2003
Vestibular Neuritis
NEJM 348:1027-1032, Baloh,R.W., 2003
Ten Most Commonly Asked Questions About the Psychiatric Aspects of Parkinson's Disease
The Neurologist 9:50-56, Reich,S.G. & Marsh,L., 2003
Treatment of Wilson Disease With Ammonium Tetrathiomolybdate, III. Initial Therapy in a Total of 55 Neurologically Affected Patients and Follow-up With Zinc Therapy
Arch Neurol 60:379-385, Brewer,G.J.,et al, 2003
Insights Into the Diagnosis and Treatment of Lysosomal Storage Diseases
Arch Neurol 60:322-328, Wegner,D.A.,et al, 2003
Hypnic Headache, Clinical Features, Pathophysiology, and Treatment
Neurol 60:905-909, Evers,S.&Goadsby,P.J., 2003
Painful Sensory Neuropathy
NEJM 348:1243-1255, Mendell,J.R.&Sahenk,Z., 2003
Bilateral Anterior Toxic Optic Neuropathy and the Use of Infliximab
BMJ 326:579, ten Tusscher,M.P.M.,et al, 2003
Oral Opioid Therapy for Chronic Peripheral and Central Neuropathic Pain
NEJM 348:1223-1232, 1279, Rowbotham,M.C.,et al, 2003
Chronic Low Back Pain
BMJ 326:535, Samanta,J.,et al, 2003
Neurological Aspects of Taste Disorders
Arch Neurol 60: 667-671, Heckmann,J.G.,et al, 2003
Stem Cells and Neurological Disease
JNNP 74:553-557, Barker,R.A.,et al, 2003
Randomized Trial of Pallidotomy Versus Medical Therapy for Parkinson's Disease
Ann Neurol 53:558-569, Vitek,J.L.,et al, 2003
Management of Drug and Alcohol Withdrawal
NEJM 348:1786-1795, Kosten,T.R. &O'Connor,P.G., 2003
Pacemaker Therapy for Prevention of Syncope in Patients with Recurrent Severe Vasovagal Syncope
JAMA 289:2224-2229,2272, Connolly,S.J.,et al, 2003
Weight Loss in Parkinson's Disease
Ann Neurol 53:676-679, Chen,H.,et al, 2003
Vertebral Artery Origin Angioplasty and Primary Stenting: Safety and Restenosis Rates in a Prospective Series
JNNP 74:586-590, Cloud,G.C.,et al, 2003
West Nile Encephalitis
BMJ 326:865-869, Solomon,T.,et al, 2003
Status Epilepticus: A Review of Different Syndromes, Their Current Evaluation, and Treatment
The Neurologist 9:61-76, Gaitanis,J.N. &Drislane,F.W., 2003
Evidence for Widespread Axonal Damage at the Earliest Clinical Stage of Multiple Sclerosis
Brain 126:433-437, Filippi,M.,et al, 2003
Outcome of Trigeminal Nerve Section in the Treatment of Chronic Cluster Headache
Neurol 60:1360-1362, Jarrar,R.G.,et al, 2003
Treatment of Postherpetic Neuralgia
Neurol 60:E6-E7, Lovitt,S., 2003
Why Should Neuroradiologist Study Patients with Smell Loss?
AJNR 24:556-557, Levy,L.M.&Henkin,R.I., 2003
Safety and Feasibility of a CT Protocol for Acute Stroke: Combined CT, CT Angiography, and CT Perfusion Imaging in 53 Consecutive Patients
AJNR 24:688-690, Smith,W.S.,et al, 2003
Amnesia, Cerebral Atrophy, and Autoimmunity
Lancet 361:1266, Schott,J.M., et al, 2003
Treatment of Herpes Zoster and Postherpetic Neuralgia
BMJ 326:748-750, Johnson,R.W. &Dworkin,R.H., 2003
Neurologic Complications of Anthrax
Arch Neurol 60:483-488, Meyer,M.A., 2003
Why Headache Treatment Fails
Neurol 60:1064-1070, Lipton,R.B.,et al, 2003
Cerebral Venous Thrombosis
Neurol 60:1175-1178, Cakmak,S.,et al, 2003
DHEA Treatment of Alzheimer's Disease
Neurol 60:1071-1076,1060, Wolkowitz,O.M.,et al, 2003
Association of Multidrug Resistance in Epilepsy with a Polymorphism in the Drug-Transporter Gene ABCB1
NEJM 348:1442-1448,1480, Siddiqui,A.,et al, 2003
Guidelines and Recommendations for Perfusion Imaging in Cerebral Ischemia
Stroke 34:1084-1104, Latchaw,R.E.,et al, 2003
Guidelines for the Early Management of Patients with Ischemic Stroke
Stroke 34:1056-1083, Adams,H.P.,et al, 2003
Platelet Function Under Aspirin, Clopidogrel, and Both After Ischemic Stroke
Stroke 34:849-855, Grau,A.J.,et al, 2003
Anticoagulation for Cerebral Sinus Thrombosis
Stroke 34:1054-1055, Stam,J.,et al, 2003
Stereotactic Treatment of Intracerebral Hematoma by Means of a Plasminogen Activator
Stroke 34:968-974, Teernstra,O.P.M.,et al, 2003
Cuahoga County Operation Stroke Speed of Emergency Department Evaluation and Compliance with National Institutes of Neurological Disorders and Stroke Time Targets
Stroke 34:994-998, Katzan,I.L.,et al, 2003
Emergency Calls in Acute Stroke
Stroke 34:1005-1009, Handschu,R.,et al, 2003
Secondary Prevention of Stroke in Italy
Stroke 34:1010-1014, Filippi,A.,et al, 2003
Statin-Associated Myopathy
JAMA 289:1681-1690, Thompson,P.D.,et al, 2003
The Emergency Management of Headaches
The Neurologist 9:93-98, Green,M.W., 2003
Thymectomy for Myasthenia Gravis: Analysis of Controversies--Patient Management
The Neurologist 9:77-92, Jaretzki,A. III, 2003
Memantine in Moderate-to-Severe Alzheimer's Disease
NEJM 348:1333-1341, Reisberg,B.,et al, 2003
Impact of Establishing a Primary Stroke Center at a Community Hospital on the Use of Thrombolytic Therapy
Stroke 34:e55, Lattimore,S.U.,et al, 2003
Perfusion-Weighted Magnetic Resonance Imaging Thresholds Identifying Core, Irreversibly Infarcted Tissue
Stroke 34:1425-1430, Shih,L.C.,et al, 2003
Cerebral Ischemic Events After Diagnosis of Mitral Valve Prolapse
Stroke 34:1339-1345, Avierinos,J.,et al, 2003
Anticoagulants Versus Antiplatelet Agents for Acute Ischemic Stroke
Stroke 34:1571-1572, Berge,E. &Sandercock,P., 2003
Evacuation of Intracerebral Hematoma is Likely to Be Beneficial
Stroke 34:1567-1568, Minematsu,K., 2003
Evacuation of Intracerebral Hematoma is Likely to Be Beneficial--Against
Stroke 34:1568-1569, Hankey,G.J., 2003